
Lanraplenib
CAS No. 1800046-95-0
Lanraplenib( GS-9876 )
Catalog No. M23810 CAS No. 1800046-95-0
Lanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 61 | In Stock |
![]() ![]() |
5MG | 91 | In Stock |
![]() ![]() |
10MG | 153 | In Stock |
![]() ![]() |
25MG | 275 | In Stock |
![]() ![]() |
50MG | 408 | In Stock |
![]() ![]() |
100MG | 600 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameLanraplenib
-
NoteResearch use only, not for human use.
-
Brief DescriptionLanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.
-
DescriptionLanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.
-
In Vitro——
-
In Vivo——
-
SynonymsGS-9876
-
PathwayAngiogenesis
-
TargetSyk
-
RecptorSYK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1800046-95-0
-
Formula Weight443.5
-
Molecular FormulaC23H25N9O
-
Purity>98% (HPLC)
-
SolubilityDMSO:41.67 mg/mL (93.96 mM; Need ultrasonic)
-
SMILESC1CN(CCN1C2COC2)C3=CC=C(C=C3)NC4=NC(=CN5C4=NC=C5)C6=CN=CC(=N6)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Di Paolo J, et al. FRI0049 Preclinical Characterization of GS-9876, A Novel, Oral SYK Inhibitor That Shows Efficacy in Multiple Established Rat Models of Collagen-Induced Arthritis.Annals of the Rheumatic Diseases 2016;75:443-444.
molnova catalog



related products
-
Lanraplenib
Lanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.
-
SecinH3
SecinH3 is selective cytohesin inhibitor.
-
Amylmetacresol
Amylmetacresol is used in the treatment of sore throat or ‘acute sore throat’, pharyngitis, tonsillitis and laryngitis. As well as in the treatment of influenza A and SARS-CoV.